Efficacy of Crizotinib After Entrectinib Resistance Due to MET Polysomy in ROS1-Rearranged NSCLC: A Case Report

por Takakura, Toshiaki, Kanemura, Hiroaki, Sakai, Kazuko, Nishio, Kazuto, Nakagawa, Kazuhiko, Hayashi, Hidetoshi
Publicado 2023

CD24, not CD47, negatively impacts upon response to PD‐1/L1 inhibitors in non–small‐cell lung cancer with PD‐L1 tumor proportion score < 50

por Ozawa, Yuichi, Harutani, Yuhei, Oyanagi, Jun, Akamatsu, Hiroaki, Murakami, Eriko, Shibaki, Ryota, Hayata, Atsushi, Sugimoto, Takeya, Tanaka, Masanori, Takakura, Toshiaki, Furuta, Katsuyuki, Okuda, Yuka, Sato, Kouichi, Teraoka, Shunsuke, Ueda, Hiroki, Tokudome, Nahomi, Kitamura, Yuka, Fukuoka, Junya, Nakanishi, Masanori, Koh, Yasuhiro, Yamamoto, Nobuyuki
Publicado 2020